APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Olanzapine

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.

Selected research

Industry Growth & Trends

Global Olanzapine Industry Growth and Trends Forecast to 2032

Report ID 174018520122 December 2025108 pages

Choose your research edition.

Industry ResearchOlanzapine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Olanzapine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Olanzapine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olanzapine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Olanzapine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.

Global Olanzapine key players include Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Hansoh Pharmaceutical, etc. Global top five manufacturers hold a share over 85%.

North America is the largest market, with a share over 70%, followed by Asia, which has a share over 25%.

Read the full market overview

In terms of product, Patent is the largest segment, with a share about 55%. And in terms of application, the largest application is Olanzapine Tablets, followed by Daily Commodities, etc.

Report Scope

This report provides a structured, data-driven view of the global Olanzapine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Olanzapine market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Olanzapine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Olanzapine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Olanzapine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Olanzapine Market by Company

Lilly

Teva Pharmaceutical

Dr. Reddy's Laboratories

Apotex Inc.

Mylan Pharmaceuticals

Par Pharmaceutical

Aurobindo Pharma

Torrent Pharmaceuticals

Jubilant Lifesciences

Sun Pharmaceutical

Sandoz

Hansoh Pharmaceutical

WATSON Pharmaceuticals(Changzhou)

Zhejiang Langhua Pharmaceuticals

Olanzapine Segment by Type

Patent

Generics

Olanzapine Segment by Application

Olanzapine Tablets

Others

Olanzapine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olanzapine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olanzapine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olanzapine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Olanzapine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Olanzapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Patent Table 2. Major Company of Generics Table 3. Global Olanzapine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Olanzapine Sales by Type (2021-2026) & (Kg) Table 5. Global Olanzapine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Olanzapine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Olanzapine Sales Market Share in Value by Type (2021-2026) Table 8. Global Olanzapine Price by Type (2021-2026) & (USD/Kg) Table 9. Global Olanzapine Sales by Type (2027-2032) & (Kg) Table 10. Global Olanzapine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Olanzapine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Olanzapine Sales Market Share in Value by Type (2027-2032) Table 13. Global Olanzapine Price by Type (2027-2032) & (USD/Kg) Table 14. North America Olanzapine Sales by Type (2021-2026) & (Kg) Table 15. North America Olanzapine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Olanzapine Sales by Type (2021-2026) & (Kg) Table 17. Europe Olanzapine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Olanzapine Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Olanzapine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Olanzapine Sales by Type (2021-2026) & (Kg) Table 21. Latin America Olanzapine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Olanzapine Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Olanzapine Sales by Type (2021-2026) & (US$ Million) Table 24. Olanzapine Industry Trends Table 25. Olanzapine Industry Drivers Table 26. Olanzapine Industry Opportunities and Challenges Table 27. Olanzapine Industry Restraints Table 28. Global Olanzapine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Olanzapine Revenue Market Share by Company (2021-2026) Table 30. Global Olanzapine Sales by Company (2021-2026) & (Kg) Table 31. Global Olanzapine Sales Share by Company (2021-2026) Table 32. Global Olanzapine Market Price by Company (2021-2026) & (USD/Kg) Table 33. Global Olanzapine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Olanzapine Major Company Production Sites and Headquarters Table 35. Global Olanzapine Company, Product Type & Application Table 36. Global Olanzapine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Olanzapine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Olanzapine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Olanzapine Sales by Region (2021-2026) & (Kg) Table 41. Global Olanzapine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Olanzapine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Olanzapine Sales Market Share in Value by Region (2021-2026) Table 44. Global Olanzapine Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 45. Global Olanzapine Sales by Region (2027-2032) & (Kg) Table 46. Global Olanzapine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Olanzapine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Olanzapine Sales Market Share in Value by Region (2027-2032) Table 49. Global Olanzapine Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 50. Global Olanzapine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Olanzapine Sales by Application (2021-2026) & (Kg) Table 52. Global Olanzapine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Olanzapine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Olanzapine Sales Market Share in Value by Application (2021-2026) Table 55. Global Olanzapine Price by Application (2021-2026) & (USD/Kg) Table 56. Global Olanzapine Sales by Application (2027-2032) & (Kg) Table 57. Global Olanzapine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Olanzapine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Olanzapine Sales Market Share in Value by Application (2027-2032) Table 60. Global Olanzapine Price by Application (2027-2032) & (USD/Kg) Table 61. North America Olanzapine Sales by Application (2021-2026) & (Kg) Table 62. North America Olanzapine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Olanzapine Sales by Application (2021-2026) & (Kg) Table 64. Europe Olanzapine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Olanzapine Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Olanzapine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Olanzapine Sales by Application (2021-2026) & (Kg) Table 68. Latin America Olanzapine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Olanzapine Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Olanzapine Sales by Application (2021-2026) & (US$ Million) Table 71. Lilly Company Information Table 72. Lilly Business Overview Table 73. Lilly Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. Lilly Olanzapine Product Portfolio Table 75. Lilly Recent Development Table 76. Teva Pharmaceutical Company Information Table 77. Teva Pharmaceutical Business Overview Table 78. Teva Pharmaceutical Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. Teva Pharmaceutical Olanzapine Product Portfolio Table 80. Teva Pharmaceutical Recent Development Table 81. Dr. Reddy's Laboratories Company Information Table 82. Dr. Reddy's Laboratories Business Overview Table 83. Dr. Reddy's Laboratories Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Dr. Reddy's Laboratories Olanzapine Product Portfolio Table 85. Dr. Reddy's Laboratories Recent Development Table 86. Apotex Inc. Company Information Table 87. Apotex Inc. Business Overview Table 88. Apotex Inc. Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 89. Apotex Inc. Olanzapine Product Portfolio Table 90. Apotex Inc. Recent Development Table 91. Mylan Pharmaceuticals Company Information Table 92. Mylan Pharmaceuticals Business Overview Table 93. Mylan Pharmaceuticals Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 94. Mylan Pharmaceuticals Olanzapine Product Portfolio Table 95. Mylan Pharmaceuticals Recent Development Table 96. Par Pharmaceutical Company Information Table 97. Par Pharmaceutical Business Overview Table 98. Par Pharmaceutical Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 99. Par Pharmaceutical Olanzapine Product Portfolio Table 100. Par Pharmaceutical Recent Development Table 101. Aurobindo Pharma Company Information Table 102. Aurobindo Pharma Business Overview Table 103. Aurobindo Pharma Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 104. Aurobindo Pharma Olanzapine Product Portfolio Table 105. Aurobindo Pharma Recent Development Table 106. Torrent Pharmaceuticals Company Information Table 107. Torrent Pharmaceuticals Business Overview Table 108. Torrent Pharmaceuticals Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 109. Torrent Pharmaceuticals Olanzapine Product Portfolio Table 110. Torrent Pharmaceuticals Recent Development Table 111. Jubilant Lifesciences Company Information Table 112. Jubilant Lifesciences Business Overview Table 113. Jubilant Lifesciences Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 114. Jubilant Lifesciences Olanzapine Product Portfolio Table 115. Jubilant Lifesciences Recent Development Table 116. Sun Pharmaceutical Company Information Table 117. Sun Pharmaceutical Business Overview Table 118. Sun Pharmaceutical Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 119. Sun Pharmaceutical Olanzapine Product Portfolio Table 120. Sun Pharmaceutical Recent Development Table 121. Sandoz Company Information Table 122. Sandoz Business Overview Table 123. Sandoz Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 124. Sandoz Olanzapine Product Portfolio Table 125. Sandoz Recent Development Table 126. Hansoh Pharmaceutical Company Information Table 127. Hansoh Pharmaceutical Business Overview Table 128. Hansoh Pharmaceutical Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 129. Hansoh Pharmaceutical Olanzapine Product Portfolio Table 130. Hansoh Pharmaceutical Recent Development Table 131. WATSON Pharmaceuticals(Changzhou) Company Information Table 132. WATSON Pharmaceuticals(Changzhou) Business Overview Table 133. WATSON Pharmaceuticals(Changzhou) Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 134. WATSON Pharmaceuticals(Changzhou) Olanzapine Product Portfolio Table 135. WATSON Pharmaceuticals(Changzhou) Recent Development Table 136. Zhejiang Langhua Pharmaceuticals Company Information Table 137. Zhejiang Langhua Pharmaceuticals Business Overview Table 138. Zhejiang Langhua Pharmaceuticals Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 139. Zhejiang Langhua Pharmaceuticals Olanzapine Product Portfolio Table 140. Zhejiang Langhua Pharmaceuticals Recent Development Table 141. North America Olanzapine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 142. North America Olanzapine Sales by Country (2021-2026) & (Kg) Table 143. North America Olanzapine Sales Market Share by Country (2021-2026) Table 144. North America Olanzapine Sales Forecast by Country (2027-2032) & (Kg) Table 145. North America Olanzapine Sales Market Share Forecast by Country (2027-2032) Table 146. North America Olanzapine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Olanzapine Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Olanzapine Market Share by Country (2021-2026) Table 149. North America Olanzapine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Olanzapine Market Share Forecast by Country (2027-2032) Table 151. Europe Olanzapine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 152. Europe Olanzapine Sales by Country (2021-2026) & (Kg) Table 153. Europe Olanzapine Sales Market Share by Country (2021-2026) Table 154. Europe Olanzapine Sales Forecast by Country (2027-2032) & (Kg) Table 155. Europe Olanzapine Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Olanzapine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Olanzapine Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Olanzapine Market Share by Country (2021-2026) Table 159. Europe Olanzapine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Olanzapine Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Olanzapine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Olanzapine Sales by Country (2021-2026) & (Kg) Table 163. Asia-Pacific Olanzapine Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Olanzapine Sales Forecast by Country (2027-2032) & (Kg) Table 165. Asia-Pacific Olanzapine Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Olanzapine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Olanzapine Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Olanzapine Market Share by Country (2021-2026) Table 169. Asia-Pacific Olanzapine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Olanzapine Market Share Forecast by Country (2027-2032) Table 171. Latin America Olanzapine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 172. Latin America Olanzapine Sales by Country (2021-2026) & (Kg) Table 173. Latin America Olanzapine Sales Market Share by Country (2021-2026) Table 174. Latin America Olanzapine Sales Forecast by Country (2027-2032) & (Kg) Table 175. Latin America Olanzapine Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Olanzapine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Olanzapine Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Olanzapine Market Share by Country (2021-2026) Table 179. Latin America Olanzapine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Olanzapine Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Olanzapine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Olanzapine Sales by Country (2021-2026) & (Kg) Table 183. Middle East and Africa Olanzapine Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Olanzapine Sales Forecast by Country (2027-2032) & (Kg) Table 185. Middle East and Africa Olanzapine Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Olanzapine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Olanzapine Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Olanzapine Market Share by Country (2021-2026) Table 189. Middle East and Africa Olanzapine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Olanzapine Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Olanzapine Distributors List Table 194. Olanzapine Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Olanzapine Image Figure 2. Global Olanzapine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Olanzapine Market Size (2021-2032) & (US$ Million) Figure 4. Global Olanzapine Sales (2021-2032) & (Kg) Figure 5. Patent Image Figure 6. Global Patent Sales YoY Growth (2021-2032) & (Kg) Figure 7. Generics Image Figure 8. Global Generics Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Olanzapine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Olanzapine Market Share by Type 2025 VS 2032 Figure 11. North America Olanzapine Sales Market Share in Volume by Type in 2025 Figure 12. North America Olanzapine Sales Market Share in Value by Type in 2025 Figure 13. Europe Olanzapine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Olanzapine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Olanzapine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Olanzapine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Olanzapine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Olanzapine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Olanzapine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Olanzapine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Olanzapine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Olanzapine Tablets Image Figure 24. Global Olanzapine Tablets Sales YoY Growth (2021-2032) & (Kg) Figure 25. Others Image Figure 26. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 27. Global Olanzapine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Olanzapine Market Share by Application 2025 VS 2032 Figure 29. North America Olanzapine Sales Market Share in Volume by Application in 2025 Figure 30. North America Olanzapine Sales Market Share in Value by Application in 2025 Figure 31. Europe Olanzapine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Olanzapine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Olanzapine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Olanzapine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Olanzapine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Olanzapine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Olanzapine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Olanzapine Sales Market Share in Value by Application in 2025 Figure 39. North America Olanzapine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 40. North America Olanzapine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Olanzapine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Olanzapine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Olanzapine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. Europe Olanzapine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Olanzapine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Olanzapine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Olanzapine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Asia-Pacific Olanzapine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Olanzapine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Olanzapine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Olanzapine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Latin America Olanzapine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Olanzapine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Olanzapine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Olanzapine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Middle East and Africa Olanzapine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Olanzapine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Olanzapine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Olanzapine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Olanzapine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generics
Applications
  • Olanzapine Tablets
  • Others
Companies covered
  • Lilly
  • Teva Pharmaceutical
  • Dr. Reddy's Laboratories
  • Apotex Inc.
  • Mylan Pharmaceuticals
  • Par Pharmaceutical
  • Aurobindo Pharma
  • Torrent Pharmaceuticals
  • Jubilant Lifesciences
  • Sun Pharmaceutical
  • Sandoz
  • Hansoh Pharmaceutical
  • WATSON Pharmaceuticals(Changzhou)
  • Zhejiang Langhua Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Olanzapine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Olanzapine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Olanzapine Market by Type
  6. 1.3.1 Patent
  7. 1.3.2 Generics
  8. 1.4 Global Olanzapine Market Size by Type
  9. 1.4.1 Global Olanzapine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Olanzapine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Olanzapine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Olanzapine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Olanzapine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Olanzapine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Olanzapine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Olanzapine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Olanzapine Industry Trends
  2. 2.2 Olanzapine Industry Drivers
  3. 2.3 Olanzapine Industry Opportunities and Challenges
  4. 2.4 Olanzapine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Olanzapine Revenue (2021-2026)
  2. 3.2 Global Top Players by Olanzapine Sales (2021-2026)
  3. 3.3 Global Top Players by Olanzapine Price (2021-2026)
  4. 3.4 Global Olanzapine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Olanzapine Major Company Production Sites & Headquarters
  6. 3.6 Global Olanzapine Company, Product Type & Application
  7. 3.7 Global Olanzapine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Olanzapine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Olanzapine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Olanzapine Tier 1, Tier 2, and Tier 3
4 Olanzapine Regional Status and Outlook
  1. 4.1 Global Olanzapine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Olanzapine Historic Market Size by Region
  3. 4.2.1 Global Olanzapine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Olanzapine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Olanzapine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Olanzapine Forecasted Market Size by Region
  7. 4.3.1 Global Olanzapine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Olanzapine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Olanzapine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Olanzapine by Application
  1. 5.1 Olanzapine Market by Application
  2. 5.1.1 Olanzapine Tablets
  3. 5.1.2 Others
  4. 5.2 Global Olanzapine Market Size by Application
  5. 5.2.1 Global Olanzapine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Olanzapine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Olanzapine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Olanzapine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Olanzapine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Olanzapine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Olanzapine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Olanzapine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Lilly
  2. 6.1.1 Lilly Company Information
  3. 6.1.2 Lilly Business Overview
  4. 6.1.3 Lilly Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Lilly Olanzapine Product Portfolio
  6. 6.1.5 Lilly Recent Developments
  7. 6.2 Teva Pharmaceutical
  8. 6.2.1 Teva Pharmaceutical Company Information
  9. 6.2.2 Teva Pharmaceutical Business Overview
  10. 6.2.3 Teva Pharmaceutical Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceutical Olanzapine Product Portfolio
  12. 6.2.5 Teva Pharmaceutical Recent Developments
  13. 6.3 Dr. Reddy's Laboratories
  14. 6.3.1 Dr. Reddy's Laboratories Company Information
  15. 6.3.2 Dr. Reddy's Laboratories Business Overview
  16. 6.3.3 Dr. Reddy's Laboratories Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dr. Reddy's Laboratories Olanzapine Product Portfolio
  18. 6.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 6.4 Apotex Inc.
  20. 6.4.1 Apotex Inc. Company Information
  21. 6.4.2 Apotex Inc. Business Overview
  22. 6.4.3 Apotex Inc. Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Apotex Inc. Olanzapine Product Portfolio
  24. 6.4.5 Apotex Inc. Recent Developments
  25. 6.5 Mylan Pharmaceuticals
  26. 6.5.1 Mylan Pharmaceuticals Company Information
  27. 6.5.2 Mylan Pharmaceuticals Business Overview
  28. 6.5.3 Mylan Pharmaceuticals Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Pharmaceuticals Olanzapine Product Portfolio
  30. 6.5.5 Mylan Pharmaceuticals Recent Developments
  31. 6.6 Par Pharmaceutical
  32. 6.6.1 Par Pharmaceutical Company Information
  33. 6.6.2 Par Pharmaceutical Business Overview
  34. 6.6.3 Par Pharmaceutical Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Par Pharmaceutical Olanzapine Product Portfolio
  36. 6.6.5 Par Pharmaceutical Recent Developments
  37. 6.7 Aurobindo Pharma
  38. 6.7.1 Aurobindo Pharma Company Information
  39. 6.7.2 Aurobindo Pharma Business Overview
  40. 6.7.3 Aurobindo Pharma Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aurobindo Pharma Olanzapine Product Portfolio
  42. 6.7.5 Aurobindo Pharma Recent Developments
  43. 6.8 Torrent Pharmaceuticals
  44. 6.8.1 Torrent Pharmaceuticals Company Information
  45. 6.8.2 Torrent Pharmaceuticals Business Overview
  46. 6.8.3 Torrent Pharmaceuticals Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Torrent Pharmaceuticals Olanzapine Product Portfolio
  48. 6.8.5 Torrent Pharmaceuticals Recent Developments
  49. 6.9 Jubilant Lifesciences
  50. 6.9.1 Jubilant Lifesciences Company Information
  51. 6.9.2 Jubilant Lifesciences Business Overview
  52. 6.9.3 Jubilant Lifesciences Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jubilant Lifesciences Olanzapine Product Portfolio
  54. 6.9.5 Jubilant Lifesciences Recent Developments
  55. 6.10 Sun Pharmaceutical
  56. 6.10.1 Sun Pharmaceutical Company Information
  57. 6.10.2 Sun Pharmaceutical Business Overview
  58. 6.10.3 Sun Pharmaceutical Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sun Pharmaceutical Olanzapine Product Portfolio
  60. 6.10.5 Sun Pharmaceutical Recent Developments
  61. 6.11 Sandoz
  62. 6.11.1 Sandoz Company Information
  63. 6.11.2 Sandoz Business Overview
  64. 6.11.3 Sandoz Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sandoz Olanzapine Product Portfolio
  66. 6.11.5 Sandoz Recent Developments
  67. 6.12 Hansoh Pharmaceutical
  68. 6.12.1 Hansoh Pharmaceutical Company Information
  69. 6.12.2 Hansoh Pharmaceutical Business Overview
  70. 6.12.3 Hansoh Pharmaceutical Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hansoh Pharmaceutical Olanzapine Product Portfolio
  72. 6.12.5 Hansoh Pharmaceutical Recent Developments
  73. 6.13 WATSON Pharmaceuticals(Changzhou)
  74. 6.13.1 WATSON Pharmaceuticals(Changzhou) Company Information
  75. 6.13.2 WATSON Pharmaceuticals(Changzhou) Business Overview
  76. 6.13.3 WATSON Pharmaceuticals(Changzhou) Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 WATSON Pharmaceuticals(Changzhou) Olanzapine Product Portfolio
  78. 6.13.5 WATSON Pharmaceuticals(Changzhou) Recent Developments
  79. 6.14 Zhejiang Langhua Pharmaceuticals
  80. 6.14.1 Zhejiang Langhua Pharmaceuticals Company Information
  81. 6.14.2 Zhejiang Langhua Pharmaceuticals Business Overview
  82. 6.14.3 Zhejiang Langhua Pharmaceuticals Olanzapine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Zhejiang Langhua Pharmaceuticals Olanzapine Product Portfolio
  84. 6.14.5 Zhejiang Langhua Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Olanzapine Sales by Country
  2. 7.1.1 North America Olanzapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Olanzapine Sales by Country (2021-2026)
  4. 7.1.3 North America Olanzapine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Olanzapine Market Size by Country
  6. 7.2.1 North America Olanzapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Olanzapine Market Size by Country (2021-2026)
  8. 7.2.3 North America Olanzapine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Olanzapine Sales by Country
  2. 8.1.1 Europe Olanzapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Olanzapine Sales by Country (2021-2026)
  4. 8.1.3 Europe Olanzapine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Olanzapine Market Size by Country
  6. 8.2.1 Europe Olanzapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Olanzapine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Olanzapine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Olanzapine Sales by Country
  2. 9.1.1 Asia-Pacific Olanzapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Olanzapine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Olanzapine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Olanzapine Market Size by Country
  6. 9.2.1 Asia-Pacific Olanzapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Olanzapine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Olanzapine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Olanzapine Sales by Country
  2. 10.1.1 South America Olanzapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Olanzapine Sales by Country (2021-2026)
  4. 10.1.3 South America Olanzapine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Olanzapine Market Size by Country
  6. 10.2.1 South America Olanzapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Olanzapine Market Size by Country (2021-2026)
  8. 10.2.3 South America Olanzapine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Olanzapine Sales by Country
  2. 11.1.1 Middle East and Africa Olanzapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Olanzapine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Olanzapine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Olanzapine Market Size by Country
  6. 11.2.1 Middle East and Africa Olanzapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Olanzapine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Olanzapine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Olanzapine Value Chain Analysis
  2. 12.1.1 Olanzapine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Olanzapine Production Mode & Process
  7. 12.2 Olanzapine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Olanzapine Distributors
  10. 12.2.3 Olanzapine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst